Hoped-for nerve pain pill trial cancelled before starting
NCT ID NCT06715462
Summary
This was a large, late-stage study that planned to test if a new drug called N0750 could relieve pain better than two commonly used medications (Cymbalta and Lyrica) in people with painful diabetic neuropathy. The trial was designed to be very thorough, using placebos and keeping both doctors and patients unaware of who got which treatment. However, the study was withdrawn by the sponsor before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAINFUL DIABETIC PERIPHERAL NEUROPATHY (PDPN) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Eurofarma Laboratórios S.A
Itapevi, São Paulo, 06696-000, Brazil
Conditions
Explore the condition pages connected to this study.